What is the Nifty Pharma Index value today?
The latest value of Nifty Pharma Index is 21961.35 as of 6th February 2026.What is the shareholder returns of Nifty Pharma Index Index?
The Nifty Pharma Index has given the following returns in the past:- Past 1 week | 1.93%
- Past 1 month | -3.64%
- Past 3 months | -1.30%
- Past 6 months | 2.03%
- Past 1 year | -0.22%
- Past 3 years | 80.11%
- Past 5 years | 69.31%
What is the 52 week high value of Nifty Pharma Index?
The 52 week high value of Nifty Pharma Index is 23492.55, as of 6th February 2026.What is the 52 week low value of Nifty Pharma Index?
The 52 week low value of Nifty Pharma Index is 19121.10, as of 6th February 2026.What are the components of Nifty Pharma Index?
The components of Nifty Pharma Index, along with their weightage, are as follows -- Sun Pharmaceutical Industries Ltd | 23.08%
- Divi's Laboratories Ltd | 9.80%
- Cipla Ltd | 9.51%
- Dr Reddy's Laboratories Ltd | 9.32%
- Lupin Ltd | 6.73%
Nifty Pharma Index Today
NIFTY PHARMA Share Price
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ETFs tracking NIFTY PHARMA
PHARMABEES
NIFTY PHARMA Performance & Key Metrics
NIFTY PHARMA Performance & Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.63 | 5.29 | 0.73% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 3.62% | 20 | 1 |
About NIFTY PHARMA
About NIFTY PHARMA
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return-0.72% | 0.72% | -0.72% | 100.00% | Free float Mcap782.12 Weight100.00% | |
ABBOTINDIA 0.55% Return attribution0.01% | 0.55% | 0.01% | 1.82% | 14.21 Weight1.82% | |
AJANTPHARM 1.26% Return attribution0.02% | 1.26% | 0.02% | 1.53% | 11.98 Weight1.53% | |
ALKEM 0.38% Return attribution0.01% | 0.38% | 0.01% | 3.22% | 25.21 Weight3.22% | |
AUROPHARMA 0.80% Return attribution0.03% | 0.80% | 0.03% | 4.05% | 31.68 Weight4.05% | |
BIOCON 0.65% Return attribution-0.02% | 0.65% | -0.02% | 3.39% | 26.53 Weight3.39% | |
ZYDUSLIFE 1.86% Return attribution-0.05% | 1.86% | -0.05% | 2.84% | 22.19 Weight2.84% | |
CIPLA 0.25% Return attribution-0.02% | 0.25% | -0.02% | 9.51% | 74.36 Weight9.51% | |
DIVISLAB 1.91% Return attribution-0.19% | 1.91% | -0.19% | 9.80% | 76.65 Weight9.80% | |
DRREDDY 0.30% Return attribution-0.03% | 0.30% | -0.03% | 9.32% | 72.90 Weight9.32% | |
GLENMARK 1.75% Return attribution-0.06% | 1.75% | -0.06% | 3.56% | 27.87 Weight3.56% | |
IPCALAB 1.77% Return attribution-0.04% | 1.77% | -0.04% | 2.52% | 19.74 Weight2.52% | |
J B Chemicals and Pharmaceuticals Ltd JBCHEPHARM 0.44% Return attribution-0.01% | 0.44% | -0.01% | 1.93% | 15.07 Weight1.93% | |
LAURUSLABS 1.39% Return attribution-0.06% | 1.39% | -0.06% | 4.45% | 34.81 Weight4.45% | |
LUPIN 2.02% Return attribution-0.14% | 2.02% | -0.14% | 6.73% | 52.60 Weight6.73% | |
Sun Pharmaceutical Industries Ltd SUNPHARMA 0.44% Return attribution-0.10% | 0.44% | -0.10% | 23.08% | 180.52 Weight23.08% | |
TORNTPHARM 0.94% Return attribution-0.05% | 0.94% | -0.05% | 5.00% | 39.09 Weight5.00% | |
WOCKPHARMA 0.19% Return attribution0.00% | 0.19% | 0.00% | 1.42% | 11.13 Weight1.42% | |
GLAND 0.10% Return attribution0.00% | 0.10% | 0.00% | 1.88% | 14.69 Weight1.88% | |
PPLPHARMA 0.09% Return attribution0.00% | 0.09% | 0.00% | 1.26% | 9.85 Weight1.26% | |
MANKIND 0.97% Return attribution-0.03% | 0.97% | -0.03% | 2.69% | 21.03 Weight2.69% |
ETFs tracking NIFTY PHARMA Index
ETFs tracking NIFTY PHARMA Index
| ETFs | Price | Liquidity | Expense ratio | Tracking error | |
|---|---|---|---|---|---|
PHARMABEES — | — | High | 0.21% | 0.01% |
NIFTY PHARMA Events
NIFTY PHARMA Events
Dividends
Corp. Actions
Announcements
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
NIFTY PHARMA Upcoming Dividends
NIFTY PHARMA Upcoming Dividends
Cash DividendJBCHEPHARM
JBCHEPHARMEx DateEx DateFeb 11, 2026
Interim
Interim | Div/Share: ₹12.70
Dividend/Share
₹12.70
Ex DateEx Date
Feb 11, 2026
NIFTY PHARMA Past Dividends
NIFTY PHARMA Past Dividends
Cash DividendSUNPHARMA
SUNPHARMAEx DateEx DateFeb 5, 2026
Interim
Interim | Div/Share: ₹11.00
Dividend/Share
₹11.00
Ex DateEx Date
Feb 5, 2026
Cash DividendAJANTPHARM
AJANTPHARMEx DateEx DateNov 10, 2025
Interim 1
Interim 1 | Div/Share: ₹28.00
Dividend/Share
₹28.00
Ex DateEx Date
Nov 10, 2025
Cash DividendLAURUSLABS
LAURUSLABSEx DateEx DateOct 31, 2025
Interim
Interim | Div/Share: ₹0.80
Dividend/Share
₹0.80
Ex DateEx Date
Oct 31, 2025
Cash DividendGLENMARK
GLENMARKEx DateEx DateOct 3, 2025
Interim
Interim | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Oct 3, 2025
Cash DividendGLENMARK
GLENMARKEx DateEx DateSep 15, 2025
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2025
NIFTY PHARMA News & Opinions
NIFTY PHARMA News & Opinions
Articles & Videos
Sensex falls over 400 pts, Nifty below 25,650; metal, pharma stocks bleed
2 days ago•Economic Times
Biopharma Shakti: India targets China dependence, patent cliff
2 days ago•Economic Times
Historic Tariff Cut To Strengthen CM Yogi Adityanath’s Vision Of A $1 Trillion Economy
3 days ago•Free Press Journal
Uttar Pradesh emerging as leading hub for pharma industry: CM Yogi Adityanath
3 days ago•The Hindu
Mankind Pharma shares in focus after Q3 net profit rises 8%YoY to Rs 414 crore
3 days ago•Economic Times
Dr. Reddy and Cipla: Growth in the post-Lenalidomide era for pharma stocks
4 days ago•The Hindu Businessline
Sun Pharma shares end nearly 1% higher post earnings announcement
6 days ago•The Hindu Businessline
‘Budget 2026 roadmap for Vikshit Bharat’: PM Modi highlights empowered feminine strength
6 days ago•Economic Times
PM Modi terms Union Budget 2026-27 ‘highway of opportunities’, says it reflects empowered presence of nation’s feminine strength
6 days ago•Economic Times
Sun Pharma shares rally 4% as Q3 profit surges 16% YoY; co announces interim dividend
6 days ago•Economic Times
